2
CANCER DISCOVERY MARCH 2019 VOLUME 9 NUMBER 3 24.373 March 2019 Volume 28 Number 3 Cancer Epidemiology, Bi omarkers & Prevention Translating Science to Populations In collaboration with the AACR Molecular Epidemiology Group and the American Society of Preventive Oncology www.AACRJournals.org CEBPFOCUS: POPULATION HEALTH ASSESSMENT IN CANCER CENTER CATCHMENT AREAS Cancer Immunology Research Illuminating the Interplay of Cancer and the Immune System In collaboration with www.AACRJournals.org March 2019 Volume 7 Number 3 March 2019 Volume 12 Number 3 www.AACRJournals.org Cancer Prevention Research The Forefront of Prevention Science March 1, 2019 Volume 25 Number 5 Clinical Cancer Research The Journal of Clinical and Translational Research www.AACRJournals.org March 2019 Volume 17 Number 3 Molecular Cancer Research Defining the Molecular Basis of Malignancy and Progression www.AACRJournals.org IN THIS ISSUE www.AACRJournals.org Cancer Research The Foundational Cancer Journal Driving Transformative Science March 1, 2019 Volume 79 Number 5 March 2019 Volume 18 Number 3 Molecular Cancer Therapeutics The Journal of Cancer Drug Discovery and Preclinical Development www.AACRJournals.org Trusted and Timely Publication of Scientific Discoveries AACR JOURNAL PORTFOLIO WHO WE ARE SMALL JOURNAL PORTFOLIO, BIG IMPACT NEW JOURNAL LAUNCHED IN 2020 Margaret Foti, PhD, MD (hc), AACR Chief Executive Officer “The mission of the American Association for Cancer Research is to prevent and cure cancer through research, education, communication, and collaboration.” ¢ Founded in 1907 ¢ First and largest scientific organization focused on cancer research ¢ Over 46,000 members working in basic, translational, and clinical research ¢ Publish 9 peer-reviewed, authoritative journals covering advances in the causes, diagnosis, treatment, and prevention of cancer ¢ Journal editors and editorial boards recognized as preeminent in the field *According to Clarivate Web of Science Journal Citation Reports™ (JCR) 2020. ¢ 4 of the AACR journals rank in the top 25 by Impact Factor in the Oncology category* ¢ AACR journals represent 3% of all of the journals in the Oncology category but receive 14% of all citations worldwide* ¢ Cancer Discovery ranks 6th in the Oncology category, with its fifth Impact Factor of 29.497* Journal Impact Factor Cancer Discovery 29.497 Cancer Epidemiology, Biomarkers & Prevention 4.344 Cancer Immunology Research 8.728 Cancer Prevention Research 3.473 Cancer Research 9.727 Clinical Cancer Research 10.107 Molecular Cancer Research 4.630 Molecular Cancer Therapeutics 5.615 BLOOD CANCER DISCOVERY A New Journal from the AACR Blood Cancer Discovery provides a critical outlet for high-impact basic, translational, and clinical research on all disease subtypes of leukemia, lymphoma, myeloma, and associated diseases. For more information regarding Blood Cancer Discovery, please go to AACRJournals.org/BCD 2007023

Trusted and Timely Publication of Scientific …...AACR Journals Suite Licensed* access to all journals in the portfolio Blood Cancer Discovery Features high-impact, peer-reviewed

  • Upload
    others

  • View
    0

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Trusted and Timely Publication of Scientific …...AACR Journals Suite Licensed* access to all journals in the portfolio Blood Cancer Discovery Features high-impact, peer-reviewed

CANCERDISCOVERY

MARCH 2019 VOLUME 9 NUMBER 3

24.373

March 2019Volume 28Number 3

CancerEpidemiology, Biomarkers& Prevention Translating Science to Populations

In collaboration with theAACR Molecular Epidemiology Group and the American Society of Preventive Oncologywww.AACRJournals.org

CEBP FOCUS:

POPULATION HEALTH ASSESSMENT

IN CANCER CENTER CATCHMENT AREAS

CancerImmunology Research Illuminating the Interplay of

Cancer and the Immune System

In collaboration with

www.AACRJournals.org

March 2019Volume 7Number 3

March 2019Volume 12Number 3

www.AACRJournals.org

CancerPrevention Research The Forefront of Prevention Science

March 1, 2019Volume 25Number 5

ClinicalCancerResearchThe Journal of Clinical and Translational Research

www.AACRJournals.org

March 2019

Volume 17

Number 3

MolecularCancerResearch Defining the Molecular Basis of

Malignancy and Progression

www.AACRJournals.org

IN THIS ISSUE

www.AACRJournals.org

CancerResearch The Foundational Cancer Journal

Driving Transformative Science

March 1, 2019

Volume 79

Number 5

March 2019Volume 18Number 3

MolecularCancerTherapeutics The Journal of Cancer Drug Discovery and Preclinical Development

www.AACRJournals.org

Trusted and Timely Publication of Scientific DiscoveriesAACR JOURNAL PORTFOLIO

WHO WE ARE

SMALL JOURNAL PORTFOLIO, BIG IMPACT NEW JOURNAL LAUNCHED IN 2020

Margaret Foti, PhD, MD (hc), AACR Chief Executive Officer

“The mission of the American Association for Cancer Research is to prevent and cure cancer through research, education, communication, and collaboration.”

¢ Founded in 1907 ¢ First and largest scientific organization focused on cancer research ¢ Over 46,000 members working in basic, translational, and clinical research ¢ Publish 9 peer-reviewed, authoritative journals covering advances in the causes,

diagnosis, treatment, and prevention of cancer ¢ Journal editors and editorial boards recognized as preeminent in the field

*According to Clarivate Web of Science Journal Citation Reports™ (JCR) 2020.

¢ 4 of the AACR journals rank in the top 25 by Impact Factor in the Oncology category*

¢ AACR journals represent 3% of all of the journals in the Oncology category but receive 14% of all citations worldwide*

¢ Cancer Discovery ranks 6th in the Oncology category, with its fifth Impact Factor of 29.497*

Journal Impact Factor

Cancer Discovery 29.497

Cancer Epidemiology, Biomarkers & Prevention 4.344

Cancer Immunology Research 8.728

Cancer Prevention Research 3.473

Cancer Research 9.727

Clinical Cancer Research 10.107

Molecular Cancer Research 4.630

Molecular Cancer Therapeutics 5.615

BLOOD CANCER DISCOVERY

COMING IN 2020 ■ VOLUME 1 ■ NUMBER 1

www.aacrjournals.org

A New Journal from the AACR

Blood Cancer Discovery provides a critical outlet for high-impact basic, translational, and clinical research on all disease subtypes of leukemia, lymphoma, myeloma, and associated diseases.

For more information regarding Blood Cancer Discovery, please go to AACRJournals.org/BCD

2007023

Page 2: Trusted and Timely Publication of Scientific …...AACR Journals Suite Licensed* access to all journals in the portfolio Blood Cancer Discovery Features high-impact, peer-reviewed

STATE OF THE ART SEARCH & DISCOVERY, AVAILABLE ANYTIME, ANYWHERE

A SOLID INVESTMENT YIELDING RESEARCH SUCCESS

¢ Available via HighWire Press since 2001 ¢ Altmetric Badges: Understand the online impact of

journal articles by viewing the Altmetric Attention Score¢ Easy to use interface enhancing readability

and navigation¢ Mobile-optimized interface providing full-text readability

on the go ¢ Produce complete results with one seamless search using

the cross-journal search feature¢ Determine which articles to explore further with an

instant abstract preview on the search results page

¢ Track your institution’s usage via COUNTER-compliant usage reports generated at your request

PURCHASE OPTIONS

AACR Journals SuiteLicensed* access to all journals in the portfolio

Blood Cancer Discovery Features high-impact, peer-reviewed articles describing major advances in basic, translational, and clinical research on all subtypes of leukemia, lymphoma, myeloma, and associated diseases

Cancer Discovery The essential information source to serve the diverse professional community in cancer science and medicine

Cancer Epidemiology, Biomarkers & Prevention Translating science to populations

Cancer Immunology Research Illuminating the interplay of cancer and the immune system

Cancer Prevention Research The forefront of prevention science

Cancer Research Driving innovation to prevent and cure cancer

Clinical Cancer Research Clinical and translational research bridging the laboratory and the clinic

Molecular Cancer Research Defining the molecular basis of malignancy and progression

Molecular Cancer Therapeutics The journal of cancer drug discovery and preclinical development

Other Options

¢ Combo Licensed* access to Cancer Research and Clinical Cancer Research

¢ Combo +1 Licensed* access to Cancer Research, Clinical Cancer Research, and one other journal

¢ Combo +2 Licensed* access to Cancer Research, Clinical Cancer Research, and two other journals

*All licenses have print purchase options. Contact sales for details.

¢ Added-value archival package includes back to volume 1, issue 1 for each journal

¢ Available anytime, anywhere at the point of need via desktop, tablet, and other mobile devices

FOR INFORMATION REGARDING A TRIAL AND A QUOTE CONTACT:

Karola RacAssistant Director, Institutional Sales and Outreach, [email protected] | AACRJournals.org/Subscribers

2007023